The important role of connexin 43 in subarachnoid hemorrhage-induced cerebral vasospasm

J Transl Med. 2019 Dec 30;17(1):433. doi: 10.1186/s12967-019-02190-1.

Abstract

Background: Gap junctions are involved in the development of cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH). However, the specific roles and regulatory functions of related connexin isoforms remain unknown. The aim of this study was to investigate the importance of connexin 43 (Cx43) in CVS and determine whether Cx43 alterations are modulated via the protein kinase C (PKC) signaling transduction pathway.

Methods: Oxyhemoglobin (OxyHb)-induced smooth muscle cells of basilar arterial and second-injection model in rat were used as CVS models in vitro and in vivo. In addition, dye transfer assays were used for gap junction-mediated intercellular communication (GJIC) observation in vitro and delayed cerebral ischemia (DCI) was observed in vivo by perfusion-weighted imaging (PWI) and intravital fluorescence microscopy.

Results: Increase in Cx43 mediated the development of SAH-induced CVS was found in both in vitro and in vivo CVS models. Enhanced GJIC was observed in vitro CVS model, this effect and increased Cx43 were reversed by preincubation with specific PKC inhibitors (chelerythrine or GF 109203X). DCI was observed in vivo on day 7 after SAH. However, DCI was attenuated by pretreatment with Cx43 siRNA or PKC inhibitors, and the increased Cx43 expression in vivo was also reversed by Cx43 siRNA or PKC inhibitors.

Conclusions: These data provide strong evidence that Cx43 plays an important role in CVS and indicate that changes in Cx43 expression may be mediated by the PKC pathway. The current findings suggest that Cx43 and the PKC pathway are novel targets for developing treatments for SAH-induced CVS.

Keywords: Cerebral vasospasm; Connexin 43; Gap junction; Protein kinase C; Subarachnoid hemorrhage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Basilar Artery / pathology
  • Cells, Cultured
  • Connexin 43 / metabolism*
  • Disease Models, Animal
  • Gap Junctions / drug effects
  • Gap Junctions / metabolism
  • Male
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism
  • Oxyhemoglobins / pharmacology
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • RNA, Small Interfering / metabolism
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Subarachnoid Hemorrhage / complications*
  • Subarachnoid Hemorrhage / metabolism*
  • Vasospasm, Intracranial / etiology*
  • Vasospasm, Intracranial / metabolism*

Substances

  • Connexin 43
  • Oxyhemoglobins
  • Protein Kinase Inhibitors
  • RNA, Small Interfering
  • Protein Kinase C